Evidence map›Paper›PMID 31465136›Full record

ArticleEuropean journal of cancer care2019

Complementing clinical cancer registry data with patient reported outcomes: A feasibility study on routine electronic patient-reported outcome assessment for the Austrian Myelome Registry.

Monika Sztankay, Lucia Neppl, Lisa M Wintner, Fanny L Loth, Wolfgang Willenbacher, Roman Weger, Walpurga Weyrer, Michael Steurer, Gerhard Rumpold, Bernhard Holzner

Abstract read
In one paragraph

Article in European journal of cancer care, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Adaptation of digital integration of PROMs and PREMs in oncology during implementation: a scoping review.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Observational
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Monika SztankayMedical University of Innsbruck, Innsbruck, Tirol, Austria.ORCID https://orcid.org/0000-0002-7938-1250
Lucia NepplPsychiatry II, Innsbruck University Hospital, Innsbruck, Tirol, Austria.
Lisa M WintnerMedical University of Innsbruck, Innsbruck, Tirol, Austria.
Fanny L LothPsychiatry II, Innsbruck University Hospital, Innsbruck, Tirol, Austria.
Wolfgang WillenbacherInternal Medicine V: Haematology & Oncology, Innsbruck University Hospital, Innsbruck, Tirol, Austria.
Roman WegerOncotyrol-Center for Personalized Cancer Medicine, Innsbruck, Tirol, Austria.
Walpurga WeyrerInternal Medicine V: Haematology & Oncology, Innsbruck University Hospital, Innsbruck, Tirol, Austria.
Michael SteurerInternal Medicine V: Haematology & Oncology, Innsbruck University Hospital, Innsbruck, Tirol, Austria.
Gerhard RumpoldMedical University of Innsbruck, Innsbruck, Tirol, Austria.
Bernhard HolznerMedical University of Innsbruck, Innsbruck, Tirol, Austria.

Funding

Austrian Science Fund #P 26930
6 · The paper itself

Abstract

objectivesRoutinely assessed patient-reported outcomes (PROs), such as quality of life (QOL), are important to supplement clinical cancer data but requires rigorous implementation. This study aims at depicting the implementation procedure and evaluating the feasibility of routine electronic PRO monitoring (ePRO) for collecting data supplementing the Austrian Myeloma Registry (AMR).

methodsIntegration of ePRO monitoring into clinical routine was planned according to the Replicating Effective Programs framework. QOL data were assessed regularly during treatment and aftercare at the hematooncological outpatient unit at the Medical University of Innsbruck with the EORTC QLQ-C30/ +MY20 and the EQ-5D-5L. Feasibility and usability testing were performed via a multimethod approach.

resultsWithin the first year, 94.4% of the MM patients (N = 142, mean age 65.4, SD 11.8, 60% male) provided 748 PRO assessment time points overall. Patients and clinicians were satisfied with ePRO monitoring and indicated no to little disruption in clinical routine. Patient preference on assessment time points and completion frequency became evident.

conclusionsComplementing the AMR with ePRO data proved to be feasible. Our findings provide useful insights for healthcare providers considering introducing ePRO monitoring to their units for informing clinical registries as well as individualised feedback to patients alike.

Indexed as

Patient Reported Outcome MeasuresRegistriesAdultAgedAged, 80 and overAttitude of Health PersonnelAustriaFeasibility StudiesFemaleHealth Information SystemsHealth PersonnelHealth Plan ImplementationHumansMaleMiddle AgedMultiple Myelomacancer registryclinical routineelectronic patient-reported outcome monitoringhealth-related quality of lifeimplementationmultiple myeloma

Identifiers

PMID31465136
PMCPMC6900154

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.